Дифференцированный подход в диагностике, формулировке диагноза, ведении больных и статистическом учете инфаркта миокарда 2 типа (согласованная позиция)

инфаркт миокарда, инфаркт миокарда 2 типа, инфаркт миокарда без обструктивного поражения коронарных артерий, диагностика, формулировка диагноза, лечение, статистический учет

1. Thygesen K, Alpert JS, White HD; Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-38.

2. Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial injury. Clin Chem. 2017;63:101-7. doi:10.1373/clinchem.2016.255521.

3. Baron T, Hambraeus K, Sundstrom J, et al. TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice. Heart. 2015;101:101-6. doi:10.1136/heartjnl-2014-306093.

4. Saaby L, Poulsen TS, Diederichsen ACP, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med. 2014;127:295-302. doi:10.1016/j.amjmed.2013.12.020.

5. Diaz-Garzon J, Sandoval Y, Smith SW, et al. Discordance between ICD-coded myocardial infarction and diagnosis according to the universal definition of myocardial infarction. Clin Chem. 2017;63:415-9.

6. Arora S, Strassle PD, Qamar A, et al. Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting. J Am Heart Assoc. 2018;7:e008661. doi:10.1161/JAHA.118.008661.

7. Saaby L, Svenstrup Poulsen T, Hosbond S, et al. Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction. Am J Med. 2013;126(9):789-97 doi:10.1016/j.amjmed.2013.02.029.

8. Gupta S, Vaidya SR, Arora S, et al. Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies. Cardiovasc Diagn Ther. 2017;7:348-58.

9. Оганов Р. Г., Симаненков В. И., Бакулин И.Г., и др. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019;18(1):5-66. doi:1015829/1728-8800-2019-1-5-66.

10. Эрлих А. Д., Барбараш О.Л., Кашталап В. В., и др. Степень следования клиническим руководствам при остром коронарном синдроме без подъема ST: связь с исходами, предикторы “плохого” лечения (результаты регистра “Рекорд-3”). Комплексные проблемы сердечно-сосудистых заболеваний. 2016;2:75-82. doi:10.17802/2306-1278-2016-2-75-82.

11. Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction-patient characteristics, management and outcomes. PLoS One. 2014;9(1):e84285. doi:10.1371/ journal.pone.0084285.

12. Chapman AR, Shah ASV, Lee KK, et al. Long term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137:1236-45. doi:101136/heartjnl-2016-309890.113.

13. Spatz ES, Curry LA, Masoudi FA, et al. The variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) classification system: a taxonomy for young women with acute myocardial infarction. Circulation. 2015;132:1710-8. doi:10.1161/CIRCULATIONAHA.115.016502.

14. Sarkisian L, Saaby L, Poulsen TS, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevatedtroponins. Am J Med. 2016;129:446.e5-21. doi:10.1016/j.amjmed.2015.11.006.

15. Gaggin HK, Liu Y, Lyass A, et al. Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography. Circulation. 2017;135:116-27. doi:10.1161/CIRCULATIONAHA.116.023052.

16. Scalone G, Niccoli G, Crea F. Pathophysiology, diagnosis and management of MINOCA: an update. Eur Heart J: Acute Cardiovasc Care. 2019;8(1):54-62. doi:10.1177/2048872618782414.

17. Eleid MF, Tweet MS, Young PM, et al. Spontaneous coronary artery dissection: challenges of coronary computed tomography angiography. Eur Heart J: Acute Cardiovasc Care. 2017;7(7):609-13. doi:10.1177/2048872616687098.

18. Cediel G, Gonzalez-del-Hoyo M, Carrasquer A, et al. Outcomes with type 2 myocardial infarction compared with non-ischemic myocardial injury. Heart. 2017;103:616-22. doi:10.1136/heartjnl-2016-310243.

19. Baron T, Hambraeus K, Sundstrom J, et al. Total-AMI study group. Impact on long¬term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction. Am J Med. 2016;129:398-406. doi:10.1016/j.amjmed.2015.11.035.

20. Shah AS, Mc Allister DA, Mills R, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med. 2015;128:493-501. doi:10.1016/j.amjmed.2014.10.056.

21. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618-e651. doi:10.1161/CIR.0000000000000617.

22. Четвертое универсальное определение инфаркта миокарда (2018). Российский кардиологический журнал. 2019;(3):107-38. doi:1015829/1560-4071-2019-3-107-138.

23. Hackworthy RA, Vogel MB, Harris PJ. Effect of spontaneous reperfusion on myocardial infarct size. Clin Cardiol. 1987;10:168-74.

24. Ishihara M, Inoue I, Kawagoe T, et al. Impact of spontaneous anterograde flow of the infarct artery on left ventricular function in patients with a first anterior wall acute myocardial infarction. Am J Cardiol. 2002;90:5-9.

25. Rimar D, Crystal E, Battler A., et al. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart. 2002;88:352-6.

26. Taher T, FuY, Wagner G, et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol. 2004;44(1):38-43.

27. Калинская А. И., Уразовская И.Л, Васильева Е. Ю., и др. Спонтанный тромболизис у больных с острым инфарктом миокарда с подъемом сегмента ST. Креативная кардиология. 2012;1:19-25.

28. Manchurov V, Ryazankina N, Khmara T, et al. Remote ischemic preconditioning and endothelial function in patients with acute myocardial infarction and primary PCI. Am J Med. 2014;127(7):670-3. doi:10.1016/j.amjmed.2014.02.012.

29. Smith SW, Pearce LA, Murakami MM, et al. Diagnosis of Type I versus Type II myocardial infarction in emergency department patients with ischemic symptoms. Annals of Emergency Medicine. 2011;58(4S):S211-S212.

30. Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med. 2014;127:105-8. doi:10.1016/j.amjmed.2013.09.031.

31. Sandoval Y, Smith SW, Thordsen SE, et al. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol. 2014;63:2079-87. doi:10.1016/j.jacc.2014.02.541.

32. Smilowitz NR, Naoulou B, Sedlis SP. Diagnosis and management of type II myocardial infarction: increased demand for a limited supply of evidence. Curr Atheroscler Rep. 2015;17:478. doi:10.1007/s11883-014-0478-1.

33. Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease. A scientific statement from the American Heart Association. Circulation. 2019;139:00-00. doi:10.1161/CIR.0000000000000670.

34. Curzen N, Rana O, Nicholas Z, et al. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain? The RIPCORD study. Circ Cardiovasc Interv. 2014;7:248-55. doi: 10.1161/CIRCINTERVENTIONS.113.000978.

35. Hanratty CG, Koyama Y, Rasmussen HH, et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol. 2002;40:911-6.

36. Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414-25. doi:10.1161/CIRCULATIONAHA.111.026542.

37. Chahine RA, Feldman RL, Giles TD, et al. Amlodipine Study 160 Group. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol. 1993;21:1365-70.

38. Slavich M, Patel RS. Coronary artery spasm: current knowledge and residual uncertainties. Int J Cardiol Heart Vasc. 2016;10:47-53. doi:10.1016/j.ijcha.2016.01.003.

39. Beltrame JF, Crea F, Kaski JC, et al. on behalf of the Coronary Vasomotion Disorders International Study Group (COVADIS). The who, what, why, when, how and where of vasospastic angina. Circ J. 2016;80:289-98. doi:10.1253/circj.CJ-15-1202.

40. Beltrame JF, Crea F, Camici P. Advances in coronary microvascular dysfunction. Heart Lung Circ. 2009;18:19-27. doi:10.1016/j.hlc.2008.11.002.

41. Lerman A, Burnett JCJr, Higano ST, et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:2123-8.

42. Kayikcioglu M, Payzin S, Yavuzgil O, et al. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J. 2003;24:1999-2005.

43. Kaski JC, Rosano G, Gavrielides S, et al. Effects of angiotensinconverting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol. 1994;23:652-7.

44. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol. 2001;87:777-9, A8.

45. Saha S, Ete T, Kapoor M, et al. Effect of ranolazine in patients with chest pain and normal coronaries- a hospital based study. J Clin Diagn Res. 2017;11:OC14-OC16. doi:10.7860/JCDR/2017/24405.9617.

46. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330:1411-7. doi:10.1056/NEJM199405193302003.

47. Elliott PM, Krzyzowska-Dickinson K, Calvino R, et al. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart. 1997;77:523-6.

48. Tweet MS, Eleid MF, Best PJ, et al. Spontaneous coronary artery dissection: revascularization versus conservative therapy. Circ Cardiovasc Interv. 2014;7:777-86. doi:10.1161/CIRCINTERVENTIONS.114.001659.

49. Mahmoud AN, Taduru SS, Mentias A, et al. Trends of incidence, clinical presentation, and in-hospital mortality among women with acute myocardial infarction with or without spontaneous coronary artery dissection: a population-based analysis. JACC Cardiovasc Interv. 2018;11:80-90. doi:10.1016/j.jcin.2017.08.016.

50. Saw J, Mancini GBJ, Humphries KH. Contemporary review on spontaneous coronary artery dissection [published correction appears in J Am Coll Cardiol. 2016;68:1606. J Am Coll Cardiol. 2016;68:297-312. doi:10.1016/j.jacc.2016.05.034.

51. Alfonso F, Bastante T, Garcla-Guimaraes M, et al. Spontaneous coronary artery dissection: new insights into diagnosis and treatment. Coron Artery Dis. 2016;27:696-706. doi:10.1097/MCA.0000000000000412.

52. Lindahl B, Baron T, Erlinge D, et al. Medical therapy for secondary prevention and longterm outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation. 2017;135:1481-9. doi:10.1161/CIRCULATIONAHA.116.026336.

53. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Version 2016. http://apps.who.int/classifications/icd10/browse/2016/en (09 Apr 2019).

54. Ly KN, Hughes EM, Jiles RB, et al. Rising mortality associated with Hepatitis C virus in the United States, 2003-2013. Clinical Infectious Diseases. 2016;62(10):12878. doi:10.1093/cid/ciw111.

55. ICD 10 Diagnosis Codes — Clinical Modification (CM). https://www.cdc.gov/nchs/icd/icd10cm.htm; https://icd10coded.com/cm (09 Apr 2019).

56. Барбараш О. Л., Бойцов С. А., Вайсман Д. Ш., и др. Проблемы оценки показателей смертности от отдельных причин. Position statement. Комплексные проблемы сердечно-сосудистых заболеваний. 2018 ;7(2):6-9. doi:10/17802/2306-1278-2018-7-2-6-9.

57. Бойцов С. А., Самородская И. В., Никулина Н. Н., и др. Сравнительный анализ смертности населения от острых форм ишемической болезни сердца за пятнадцатилетний период в РФ и США и факторов, влияю-щих на ее формирование. Терапевтический архив. 2017;89(9):53-9. doi: 10.17116/terarkh201789953-59.